Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• Wegovy is an FDA‑approved, manufacturer‑made semaglutide product with fixed formulation, dosing pens, large clinical trial evidence for weight loss, and formal safety/labeling/monitoring.
• “Compounded semaglutide” is made by compounding pharmacies (not by the drug manufacturer) and can vary in purity, potency, sterility and labeling; it is not FDA‑approved for weight management and carries additional safety and regulatory risks.

Key differences (practical terms)

• Regulatory/approval status
  • Wegovy (Novo Nordisk) — FDA approved for chronic weight management after large randomized trials. Standard label, known risks/benefits.
  • Compounded semaglutide — not FDA approved as a finished product; compounding when an approved product exists has been the subject of FDA warnings.
• Quality, purity and potency
  • Wegovy is produced under strict pharma GMP controls; potency and purity are verified by the manufacturer.
  • Compounded products may come from bulk powder of uncertain origin or use different formulations; batch‑to‑batch variability and contamination risk are possible.
• Sterility and infection risk
  • Wegovy comes in sealed, sterile, factory‑prepared pens.
  • Compounded injectables are made in pharmacy sterile compounding environments; standards vary and poor sterility has led to infections historically.
• Dosing accuracy and device
  • Wegovy uses standardized, easy prefilled pens and has a labeled titration schedule.
  • Compounded versions may require vials, syringes, custom concentrations or different instructions — greater chance of dosing errors.
• Evidence of safety/efficacy
  • Wegovy’s dose (2.4 mg weekly) and benefits/risks are backed by clinical trial data.
  • Compounded formulations generally lack trial data for safety and long‑term effects.
• Cost and access
  • Wegovy is expensive and insurance coverage is inconsistent, but manufacturer savings programs and patient support exist.
  • Compounded semaglutide is often cheaper, which is why people choose it — but the savings come with the tradeoffs above.

What the regulators have said

• The FDA has cautioned about compounded semaglutide when an FDA‑approved product is available and warned about safety/quality risks. Compounding pharmacies must follow narrow rules; mass marketing compounded copies of an approved drug is not allowed.

When compounding might be considered — and how to reduce risk

• Only consider a compounded product after talking with your prescriber if approved products are inaccessible or unaffordable. If you do:
  • Use a pharmacy accredited by PCAB (Pharmacy Compounding Accreditation Board) or that follows USP <797>/<800> sterile compounding standards.
  • Ask for a Certificate of Analysis (COA) showing identity/potency and sterility test results.
  • Confirm the origin of the active ingredient and sterility testing frequency.
  • Make sure instructions and labeling are clear and that you have a plan for follow‑up and adverse‑event reporting.

Recommended brand alternatives and why

• Wegovy (Novo Nordisk) — FDA‑approved specifically for weight management; consistent manufacturing, large clinical trials, prefilled pens and official patient support programs.
• Zepbound (tirzepatide, Eli Lilly) — FDA‑approved for weight management (different drug class: dual GIP/GLP‑1 agonist) and has shown even larger weight‑loss effects in trials; available patient support programs.
• Ozempic (semaglutide, Novo Nordisk) or Mounjaro (tirzepatide, Eli Lilly) — approved for type 2 diabetes; sometimes used off‑label for weight loss under medical supervision but dosing and labeling differ from weight‑management products.

Bottom line / recommendation If safety, consistent dosing, and proven effectiveness are priorities, choose an FDA‑approved product (Wegovy or the newer approved alternatives such as Zepbound) and discuss affordability/coverage options with your clinician and insurer. Only consider compounded semaglutide after careful discussion with your prescriber, and only from a highly reputable, accredited compounding pharmacy with verifiable testing.

If you want, I can:

• Compare rough out‑of‑pocket cost estimates for Wegovy vs alternatives in the U.S., or
• Give a short checklist of questions to ask a compounding pharmacy or your prescriber. Which would you prefer?